Incremental utility of iodine-123 meta-iodobenzylguanidine imaging beyond established heart failure risk models

Journal of Cardiac Failure

Volumn 20, Issue 8, 2014, Pages 577-583

  Jain, Kaushik K ^a   Hauptman, Paul J ^a   Spertus, John A ^b   Kennedy, Kevin F ^b   Bateman, Timothy M ^b   Jacobson, Arnold F ^c   Stolker, Joshua M ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c GE HEALTHCARE   (United States)

Author keywords

heart failure; prognosis; radionuclide imaging; Risk model

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DEXETIMIDE; N-METHYL-4-IODODEXETIMIDE; RADIOACTIVE IODINE;

AGED; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLIC HEART FAILURE; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING; UNITED STATES; UTILIZATION;

AGED; DEXETIMIDE; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84905437516     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.06.001     Document Type: Article

References (31)

1. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults J Am Coll Cardiol 53 2009 e1 e90
2. A. Gohler, J.L. Januzzi, S.S. Worrell, K.J. Osterziel, G.S. Gazelle, and R. Dietz et al. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure J Card Fail 12 2006 554 567
3. E.J. Davies, T. Moxham, K. Rees, S. Singh, A.J. Coats, and S. Ebrahim et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis Eur J Heart Fail 12 2010 706 715
4. D.J. Goldstein, M.C. Oz, and E.A. Rose Implantable left ventricular assist devices N Engl J Med 339 1998 1522 1533
5. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger Cardiac Resynchronization-Heart Failure Study Investigators The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
6. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau Sudden Cardiac Death in Heart Failure Trial Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
7. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, and J.V. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
8. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, and A.B. Cropp et al. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
9. M. Richardson, N. Freemantle, M.J. Calvert, J.G. Cleland, and L. Tavazzi Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial Eur Heart J 28 2007 1827 1834
10. I. Goldenberg, A.K. Vyas, W.J. Hall, A.J. Moss, H. Wang, and H. He et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
11. D.B. Kramer, P.A. Friedman, L.M. Kallinen, T.B. Morrison, D.J. Crusan, and D.O. Hodge et al. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators Heart Rhythm 9 2012 42 46
12. J.A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review BMJ 330 2005 625 633
13. N. Mewton, A. Opdahl, E.Y. Choi, A.L. Almeida, N. Kawel, and C.O. Wu et al. Left ventricular global function index by magnetic resonance imaging-a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the Multi-Ethnic Study of Atherosclerosis Hypertension 61 2013 770 778
14. A.F. Jacobson, R. Senior, M.D. Cerqueira, N.D. Wong, G.S. Thomas, and V.A. Lopez et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (Adreview Myocardial Imaging for Risk Evaluation in Heart Failure) study J Am Coll Cardiol 55 2010 2212 2221
15. E.S. Ketchum, A.F. Jacobson, J.H. Caldwell, R. Senior, M.D. Cerqueira, and G.S. Thomas et al. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging J Nucl Cardiol 19 2012 1007 1016
16. A.F. Jacobson, J. Lombard, G. Banerjee, and P.G. Camici 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials J Nucl Cardiol 16 2009 113 121
17. M.J. Pencina, R.B. d'Agostino Sr., R.B. d'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
18. D.A. Morrow, and E. Braunwald Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy Circulation 108 2003 250 252
19. E.S. Ketchum, and W.C. Levy Establishing prognosis in heart failure: a multimarker approach Prog Cardiovasc Dis 54 2011 86 96
20. W.C. Levy, K.D. Aaronson, T.F. Dardas, P. Williams, J. Haythe, and D. Mancini Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population J Heart Lung Transpl 31 2012 817 824
21. B. Ky, B. French, K. McCloskey, J.E. Rame, E. McIntosh, and P. Shahi et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure Circ Heart Fail 4 2011 180 187
22. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. vonScheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
23. Y. Kuramoto, T. Yamada, S. Tamaki, Y. Okuyama, T. Morita, and Y. Furukawa et al. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure Am J Cardiol 107 2011 1185 1190
24. H.J. Verberne, L.M. Brewster, G.A. Somsen, and B.L. van Eck-Smit Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur Heart J 29 2008 1147 1159
25. M. Bohm, K. la Rosee, R.H. Schwinger, and E. Erdmann Evidence for reduction of norepinephrine uptake sites in the failing human heart J Am Coll Cardiol 25 1995 146 153
26. M.R. Bristow, R. Ginsburg, W. Minobe, R.S. Cubicciotti, W.S. Sageman, and K. Lurie et al. Decreased catecholamine sensitivity and beta-adrenergic- receptor density in failing human hearts N Engl J Med 307 1982 205 211
27. T. Wakabayashi, T. Nakata, A. Hashimoto, S. Yuda, K. Tsuchihashi, and M.I. Travin et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death J Nucl Med 42 2001 1757 1767
28. H.P. Brunner-La Rocca, M.D. Esler, G.L. Jennings, and D.M. Kaye Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure Eur Heart J 22 2001 1136 1143
29. O. Costantini, S.H. Hohnloser, M.M. Kirk, B.B. Lerman, J.H. Baker 2nd, and B. Sethuraman et al. The ABCD (Alternans Before Cardioverter Defibrillator) trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention J Am Coll Cardiol 53 2009 471 479
30. P. Greenland, J.S. Alpert, G.A. Beller, E.J. Benjamin, M.J. Budoff, and Z.A. Fayad et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults Circulation 122 2010 e584 e636
31. E.M. Antman, M. Cohen, P.J. Bernink, C.H. McCabe, T. Horacek, and G. Papuchis et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 284 2000 835 842